Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Phase II trials for gamma treatment for restenosis:

This article was originally published in Clinica

Executive Summary

US Surgical has said that its Vascular Therapies division could begin Phase II trials of a device for treating blocked arteries with gamma radiation in the next few weeks following successful initial studies. The Phase I trials tested the device, called the AngioRad system, in patients whose arteries had become blocked again after angioplasty or angioplasty with stenting. The device is used to place a tiny radioactive wire in the affected artery.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts